This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Donald Edward Frail
Introduction
Donald Edward Frail is a notable inventor based in Wildwood, MO (US). He has made significant contributions to the field of gene expression and hormone regulation. His work has implications for understanding the biological effects of estrogen and related therapies.
Latest Patents
Frail holds a patent titled "Estrogen receptor α regulated gene expression, related assays and therapeutics." This patent describes a plurality of genes modulated by estrogen or other agents, such as hormones or combinations of hormones, in various types of tissue. One embodiment of the disclosure relates to a plurality of genes that demonstrate certain patterns of expression differing qualitatively or quantitatively, with and without exposure to estrogen and/or other hormone compositions. The patent also outlines methods for using these genes to identify candidate agents that exert biological effects similar to those of estrogen and/or other hormones. Additionally, it discusses the use of these genes in monitoring methods, gene chips, and kits.
Career Highlights
Frail has had a distinguished career, working at Wyeth, where he has been able to apply his expertise in gene expression and hormone research. His innovative work has contributed to advancements in pharmaceuticals and related therapies.
Collaborations
Frail has collaborated with notable colleagues, including Scott Alan Jelinsky and Heather Anne Harris. These collaborations have further enriched his research and development efforts.
Conclusion
Donald Edward Frail's contributions to the field of gene expression and hormone regulation highlight his innovative spirit and dedication to advancing medical science. His patent work continues to influence research and therapeutic approaches in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
